Literature DB >> 10554416

Protective effect of nisoldipine on myocardial ischemia during coronary bypass surgery.

A Usui1, M Kawamura, F Murakami, H Oshima, K Yoshida, M Hibi, R Nakayama.   

Abstract

BACKGROUND: Nisoldipine, a calcium antagonist, was assessed for myocardial protection and the prevention of reperfusion injury in patients undergoing CABG.
METHODS: Of the 34 subjects undergoing CABG in this study, 20 were given nisoldipine orally at 10 mg/day for 2 weeks before surgery (N group) and the other 14 untreated controls (C group). Myocardial protection was conducted via ante-grade cold blood cardioplegia at 20-minute intervals.
RESULTS: Myocardial blood flow was significantly higher in the N group (67.8 +/- 21.8 ml/100 g vs. 47.2 +/- 14.4 ml/100 g, p < 0.05) after cardiopulmonary bypass. Serum interleukin-6 levels were significantly lower in the N group 1 hour after reperfusion (116 +/- 58 vs. 409 +/- 362 pg/ml, p < 0.05), as were serum lactate dehydrogenase levels immediately after surgery (888 +/- 268 vs. 1350 +/- 486 IU/L, p < 0.05). The N Group showed a better left ventricle stroke work index 6 hours after surgery (43 +/- 8 vs. 36 +/- 9 g.m/m2). Dopamine dosage in the N group on postoperative day 1 was lower than in controls (5.3 +/- 1.9 vs. 3.0 +/- 2.4 micrograms/kg/min).
CONCLUSIONS: Preoperative nisoldipine treatment increased blood flow in the postischemic myocardium and prevented myocardial damage and reperfusion injury to some extent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10554416     DOI: 10.1007/bf03218046

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  22 in total

1.  Effects of regional ischemia on metabolism of glucose and fatty acids. Relative rates of aerobic and anaerobic energy production during myocardial infarction and comparison with effects of anoxia.

Authors:  L H Opie
Journal:  Circ Res       Date:  1976-05       Impact factor: 17.367

2.  Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation.

Authors:  N Nishimoto; K Yoshizaki; H Tagoh; M Monden; S Kishimoto; T Hirano; T Kishimoto
Journal:  Clin Immunol Immunopathol       Date:  1989-03

3.  I. Development of an in vitro model of myocardial cooling: a study of the effect of cardiac size on cooling rate.

Authors:  F L Rosenfeldt; D A Watson
Journal:  Ann Thorac Surg       Date:  1979-01       Impact factor: 4.330

4.  Retroperfusion of the heart with a solution of glucose, insulin, and potassium during anoxic arrest.

Authors:  D M Lolley; R L Hewitt; T Drapanas
Journal:  J Thorac Cardiovasc Surg       Date:  1974-03       Impact factor: 5.209

5.  Protection of the myocardium against postischemic reperfusion damage. The combined effect of hypothermia and nifedipine.

Authors:  W G Nayler
Journal:  J Thorac Cardiovasc Surg       Date:  1982-12       Impact factor: 5.209

6.  Pretreatment with nicardipine preserves ventricular function after hypothermic ischemic arrest.

Authors:  P S Brown; G L Parenteau; F W Holland; R E Clark
Journal:  Ann Thorac Surg       Date:  1991-05       Impact factor: 4.330

7.  Interleukin-6 (IL-6) as a mediator of stunned myocardium.

Authors:  M S Finkel; R A Hoffman; L Shen; C V Oddis; R L Simmons; B G Hattler
Journal:  Am J Cardiol       Date:  1993-05-15       Impact factor: 2.778

8.  Calcium antagonists and hypothermia: the temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart.

Authors:  D J Hearse; F Yamamoto; M J Shattock
Journal:  Circulation       Date:  1984-09       Impact factor: 29.690

9.  Calcium-channel blockade as an adjunct to heterogeneous delivery of cardioplegia.

Authors:  R A Guyton; L M Dorsey; T K Colgan; C R Hatcher
Journal:  Ann Thorac Surg       Date:  1983-06       Impact factor: 4.330

10.  Vascular washout reduces Ca2+ overload and improves function of reperfused ischemic hearts.

Authors:  M Tani; J R Neely
Journal:  Am J Physiol       Date:  1990-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.